Michelle Juneau, MD
Dermatology · Atlanta, GANPI 1821284290
Payments from drug & device makers
Across 546 payments — averaging $22.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sanofi$2K
- Novartis$913
- Revance Therapeutics, Inc.$821
- Pfizer$712
- Regeneron Healthcare Solutions, Inc.$683
- plus $5K from 30 others
What the payments were for
- Food & beverage$12,22499%
- Education$1101%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 120 | $2,186 |
| Sanofi | 49 | $2,013 |
| Novartis | 48 | $913 |
| Revance Therapeutics, Inc. | 20 | $821 |
| Pfizer | 41 | $712 |
| Regeneron Healthcare Solutions, Inc. | 26 | $683 |
| Dermavant Sciences, Inc. | 20 | $549 |
| E.r. Squibb & Sons, L.L.C. | 25 | $548 |
| Amgen | 19 | $503 |
| LEO Pharma Inc. | 23 | $497 |
| Sun Pharmaceutical Industries Inc. | 23 | $402 |
| Johnson & Johnson | 16 | $398 |
| Arcutis Biotherapeutics, Inc. | 19 | $374 |
| Galderma Laboratories, L.p. | 16 | $319 |
| Lilly USA, LLC | 17 | $299 |
| Incyte Corporation | 7 | $150 |
| Bristol Myers Squibb | 11 | $147 |
| UCB, Inc. | 8 | $147 |
| Helsinn Therapeutics (U.S.), Inc. | 5 | $96 |
| Botanix SB Inc | 4 | $77 |
| Mayne Pharma Commercial LLC | 3 | $73 |
| Strata Skin Sciences, Inc. | 7 | $61 |
| Boehringer Ingelheim | 3 | $57 |
| Organogenesis Inc. | 1 | $50 |
| Organon | 3 | $42 |
| Kerecis Limited | 2 | $35 |
| Verrica Pharmaceuticals Inc. | 1 | $26 |
| VYNE Pharmaceuticals Inc. | 1 | $25 |
| Merz North America, Inc. | 1 | $23 |
| DUSA Pharmaceuticals, Inc. | 1 | $19 |
| Biofrontera Inc. | 1 | $17 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $16 |
| Mission Pharmacal Company | 1 | $14 |
| Novum Pharma, LLC | 1 | $14 |
| Medtronic | 1 | $13 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,333 in reported general payments places this provider in the 80th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 87 | $2,920 |
| Desonide | 28 | $1,563 |
| Tacrolimus | 12 | $1,357 |
| Triamcinolone Acetonide | 109 | $1,152 |
| Ketoconazole | 87 | $1,024 |
| ValacyclovirValacyclovir Hcl | 36 | $925 |
| Clindamycin Phosphate | 28 | $610 |
| Clobetasol Propionate | 15 | $521 |
| Doxycycline Hyclate | 35 | $458 |
| Nystatin | 35 | $429 |
| Mupirocin | 49 | $309 |
| Minoxidil | 39 | $213 |
| Hydroxyzine Hcl | 20 | $200 |
| Spironolactone | 14 | $147 |
| Hydrocortisone | 30 | $144 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Atlanta
- Jamie WeismanAtlanta$4.9M
- Zakiya RiceAtlanta$1.1M
- Joseph PayneAtlanta$722K
- Ron FeldmanAtlanta$483K
- Jack ArbiserAtlanta$453K
- Mack RachalAtlanta$316K
- Tunisia CorneliusAtlanta$210K
- Emily AltmanAtlanta$178K
- Hailey RouhanaAtlanta$157K
- Lauren OrensteinAtlanta$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.